Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*

皮肤科生活质量指数 特应性皮炎 医学 生活质量(医疗保健) 湿疹面积及严重程度指数 儿科 随机对照试验 家庭医学 临床试验 物理疗法 皮肤病科 外科 疾病 护理部 病理
作者
Kim Suzanne Thomas,Christian Apfelbacher,Joanne R Chalmers,Eric Lawrence Simpson,Phyllis Ira Spuls,Louise A. A. Gerbens,Hywel C Williams,Jochen M. Schmitt,Michaela Gabes,Laura Howells,Beth L. Stuart,Erin E. Grinich,Traci Pawlitschek,Tim Burton,L Howie,A. Gadkari,Laurent Eckert,Toshiya Ebata,Maarten Boers,Hidehisa Saeki
出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:185 (1): 139-146 被引量:92
标识
DOI:10.1111/bjd.19751
摘要

BACKGROUND: The Harmonising Outcome Measures for Eczema (HOME) initiative has established a core outcome set of domains for atopic eczema (AE) clinical trials. Previous consensus meetings have agreed on preferred instruments for clinician-reported signs (Eczema Area and Severity Index, EASI) and patient-reported symptoms (Patient-Oriented Eczema Measure, POEM). This paper reports consensus decisions from the HOME VII meeting. OBJECTIVES: To complete the core outcome set for AE by agreeing on core outcome instruments for the domains of quality of life (QoL), long-term control and itch intensity. METHODS: A face-to-face consensus meeting was held in Tokyo, Japan (8-10 April 2019) including 75 participants (49 healthcare professionals/methodologists, 14 patients, 12 industry representatives) from 16 countries. Consensus decisions were made by presentations of evidence, followed by whole and small group discussions and anonymous voting using predefined consensus rules. RESULTS: It was agreed by consensus that QoL should be measured using the Dermatology Life Quality Index (DLQI) for adults, the Children's Dermatology Life Quality Index (CDLQI) for children and the Infant's Dermatology Quality of Life Index (IDQoL) for infants. For long-term control, the Recap of Atopic Eczema (RECAP) instrument or the Atopic Dermatitis Control Test (ADCT) should be used. Consensus was not reached over the frequency of data collection for long-term control. The peak itch numerical rating scale (NRS)-11 past 24 h was recommended as an additional instrument for the symptom domain in trials of older children and adults. Agreement was reached that all core outcome instruments should be captured at baseline and at the time of primary outcome assessment as a minimum. CONCLUSIONS: For now, the core outcome set for clinical trials in AE is complete. The specified domains and instruments should be used in all new clinical trials and systematic reviews of eczema treatments.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
路期完成签到,获得积分10
1秒前
xd发布了新的文献求助10
1秒前
CodeCraft的应助被yyy采纳,获得10
1秒前
2秒前
2秒前
坚定的若南完成签到,获得积分20
2秒前
郭佳雨完成签到 ,获得积分10
2秒前
zdk发布了新的文献求助10
2秒前
成熟稳重痴情完成签到,获得积分0
3秒前
3秒前
玖可柒完成签到,获得积分10
4秒前
王海祥发布了新的文献求助10
4秒前
5秒前
razor发布了新的文献求助10
5秒前
6秒前
诚心天奇发布了新的文献求助10
7秒前
周周发布了新的文献求助10
7秒前
7秒前
震动的山柳完成签到,获得积分10
8秒前
独特振家完成签到,获得积分10
9秒前
ax发布了新的文献求助10
9秒前
西贝发布了新的文献求助10
9秒前
Lucas的应助被yyy采纳,获得10
10秒前
红红发布了新的文献求助10
10秒前
侧耳倾听完成签到 ,获得积分10
11秒前
炸鲜奶的应助被razor采纳,获得10
12秒前
12秒前
小奇完成签到,获得积分10
13秒前
当时明月在的应助被呆萌立诚采纳,获得20
14秒前
科目三的应助被啦啦啦采纳,获得10
14秒前
15秒前
英俊的铭的应助被王海祥采纳,获得10
16秒前
16秒前
小赵完成签到 ,获得积分10
16秒前
LISHIAYNG发布了新的文献求助10
17秒前
虚心夏之完成签到 ,获得积分10
17秒前
慕青的应助被六六采纳,获得10
17秒前
所所的应助被周周采纳,获得10
17秒前
小顾完成签到 ,获得积分10
18秒前
诚心天奇完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168163
求助须知:如何正确求助?哪些是违规求助? 9561243
关于积分的说明 21759855
捐赠科研通 7759477
什么是DOI,文献DOI怎么找? 3429959
关于科研通互助平台的介绍 2553757
邀请新用户注册赠送积分活动 2474496